UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hormone-replacement therapy: current thinking

Nature reviews. Endocrinology, 2017-04, Vol.13 (4), p.220-231

Lobo, Roger A

2017

Volltextzugriff (PDF)

Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause

Atherosclerosis, 2016-11, Vol.254, p.282-290

2016

Volltextzugriff (PDF)

Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial

American journal of obstetrics and gynecology, 2014-11, Vol.211 (5), p.487.e1-487.e6

2014

Volltextzugriff (PDF)

Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea

American journal of obstetrics and gynecology, 2016-06, Vol.214 (6), p.714.e1-714.e6

2016

Volltextzugriff (PDF)

Management of menopause: a view towards prevention

The lancet. Diabetes & endocrinology, 2022-06, Vol.10 (6), p.457-470

2022

Volltextzugriff (PDF)

Where Are We 10 Years After the Women's Health Initiative?

The journal of clinical endocrinology and metabolism, 2013-05, Vol.98 (5), p.1771-1780

Lobo, Roger A

2013

Volltextzugriff (PDF)

Best practices of ASRM and ESHRE: a journey through reproductive medicine

Fertility and sterility, 2012-12, Vol.98 (6), p.1380-1394

2012

Volltextzugriff (PDF)

What drives metabolic syndrome after menopause, and can we do anything about it?

Menopause (New York, N.Y.), 2020-09, Vol.27 (9), p.972-973

Lobo, Roger A.

2020

Volltextzugriff (PDF)

Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?

Journal of women's health (Larchmont, N.Y. 2002), 2018-11, Vol.27 (11), p.1385-1388

2018

Volltextzugriff (PDF)

A 20-year follow-up of young women with polycystic ovary syndrome

Obstetrics and gynecology (New York. 1953), 2012-02, Vol.119 (2 Pt 1), p.263-269

2012

Volltextzugriff (PDF)

Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function

Gynecological endocrinology, 2018-04, Vol.34 (4), p.301-304

2018

Volltextzugriff (PDF)

Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement

The journal of clinical endocrinology and metabolism, 2010-07, Vol.95 (7_supplement_1), p.s1-s66

2010

Volltextzugriff (PDF)

Human embryos commonly form abnormal nuclei during development: a mechanism of DNA damage, embryonic aneuploidy, and developmental arrest

Human reproduction (Oxford), 2016-02, Vol.31 (2), p.312-323

2016

Volltextzugriff (PDF)

Do lipid parameters change during clomiphene citrate or letrozole therapy in women being treated for infertility? A pilot study

European journal of obstetrics & gynecology and reproductive biology, 2021-02, Vol.257, p.151-152

2021

Volltextzugriff (PDF)

Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome

Gynecological endocrinology, 2015-02, Vol.31 (2), p.152-155

2015

Volltextzugriff (PDF)

Words of thanks to Dr. Alan H. DeCherney

Fertility and sterility, 2011-06, Vol.95 (8), p.2437-2438

2011

Volltextzugriff (PDF)

Workshop on normal reference ranges for estradiol in postmenopausal women, September 2019, Chicago, Illinois

Menopause (New York, N.Y.), 2020-06, Vol.27 (6), p.614-624

2020

Volltextzugriff (PDF)

Inflammatory Markers and Progression of Subclinical Atherosclerosis in Healthy Postmenopausal Women (from the Estrogen in the Prevention of Atherosclerosis Trial)

The American journal of cardiology, 2008-04, Vol.101 (8), p.1131-1133

2008

Volltextzugriff (PDF)

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 2001-12, Vol.135 (11), p.939

2001

Volltextzugriff (PDF)

Preliminary Evidence that Cinnamon Improves Menstrual Cyclicity in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial

Obstetrical & gynecological survey, 2015-02, Vol.70 (2), p.94-95

2015

Volltextzugriff (PDF)

Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women

The New England journal of medicine, 2003-08, Vol.349 (6), p.535-545

2003

Volltextzugriff (PDF)

Ovarian adipocytokines are associated with early in vitro human embryo development independent of the action of ovarian insulin

Journal of assisted reproduction and genetics, 2012-12, Vol.29 (12), p.1397-1404

2012

Volltextzugriff (PDF)

Mature oocyte cryopreservation: a guideline

Fertility and sterility, 2013, Vol.99 (1), p.37-43

2013

Volltextzugriff (PDF)

Definitions of infertility and recurrent pregnancy loss: a committee opinion

Fertility and sterility, 2013, Vol.99 (1), p.63-63

2013

Volltextzugriff (PDF)

Repeated doses of GnRH antagonist at midcycle in artificial frozen embryo transfer cycles may not affect pregnancy outcomes

Gynecological endocrinology, 2017-04, Vol.33 (4), p.301-305

2017

Volltextzugriff (PDF)

1 – 25 von 265

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(163)

Publikationsform

Artikel
(201)
Buchkapitel
(62)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(31)

Menü

Weitere Dienste

Einstellungen

Hormone-replacement therapy: current thinking

Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause

Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial

Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea

Management of menopause: a view towards prevention

Where Are We 10 Years After the Women's Health Initiative?

Best practices of ASRM and ESHRE: a journey through reproductive medicine

What drives metabolic syndrome after menopause, and can we do anything about it?

Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?

A 20-year follow-up of young women with polycystic ovary syndrome

Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function

Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement

Human embryos commonly form abnormal nuclei during development: a mechanism of DNA damage, embryonic aneuploidy, and developmental arrest

Do lipid parameters change during clomiphene citrate or letrozole therapy in women being treated for infertility? A pilot study

Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome

Words of thanks to Dr. Alan H. DeCherney

Workshop on normal reference ranges for estradiol in postmenopausal women, September 2019, Chicago, Illinois

Inflammatory Markers and Progression of Subclinical Atherosclerosis in Healthy Postmenopausal Women (from the Estrogen in the Prevention of Atherosclerosis Trial)

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

Preliminary Evidence that Cinnamon Improves Menstrual Cyclicity in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial

Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women

Ovarian adipocytokines are associated with early in vitro human embryo development independent of the action of ovarian insulin

Mature oocyte cryopreservation: a guideline

Definitions of infertility and recurrent pregnancy loss: a committee opinion

Repeated doses of GnRH antagonist at midcycle in artificial frozen embryo transfer cycles may not affect pregnancy outcomes

Suchergebnisse filtern